Manage skin toxicities associated with targeted therapies.
Pamela
P
Oestreicher
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D006801:Humans; D012871:Skin Diseases / Q000139:chemically induced* / Q000628:therapy*
D000911:Antibodies, Monoclonal